Wordt geladen...
Histone deacetylase inhibitors: molecular mechanisms of action and clinical trials as anti-cancer drugs
Histone deacetylase (HDAC) inhibitors are a relatively new class of anti-cancer agents that play important roles in epigenetic or non-epigenetic regulation, inducing death, apoptosis, and cell cycle arrest in cancer cells. Recently, their use has been clinically validated in cancer patients resultin...
Bewaard in:
| Hoofdauteurs: | , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
e-Century Publishing Corporation
2010
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3056563/ https://ncbi.nlm.nih.gov/pubmed/21416059 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|